PHARM-D QUESTION PAPERS-TNMGRU

                                        PHARMACEUTICAL INORGANIC CHEMISTRY

                                 PHARMACOGNOSY AND PHYTO PHARMACEUTICALS

PHARM-D Ist YEAR QUESTION PAPERS- KERLA UNIVERSITY

 

Pharm.D I year model paper..

QUESTIONS ABOUT PHARM.D-INTERACTIVE SESSION WITH PCI MEMBER M.VENKAT REDDY

About pharm.d in eenadu newspaper

Click on image to read  the article.
SOURCE: http://www.eenadu.net (16th July 2012)

Message to DOCTOR OF PHARMACY STUDENTS

Society holds pharmacists to a high degree of duty, integrity and honor, reflecting a responsibility to their patients and their community. As developing professionals, it is the responsibility of Pharm.D students to uphold these high expectations and to conduct themselves accordingly by observing all applicable laws as well as institutional policies, regulations and guidelines.

JNTU-HYD : Pharm.D 1,2 Year's Regular Exams Notification (July 2012)

PHARM D – FIRST YEAR REGULAR EXAMINATIONS NOTIFICATION

CANDIDATES APPEARING FOR THE ABOVE EXAMINATIONS COMMENCING FROM 30-07-2012 ARE INFORMED THAT THE APPLICATIONS WILL BE RECEIVED AS PER THE TIME SCHEDULE GIVEN BELOW:

WITHOUT LATE FEE : 16-07-2012

WITH LATE FEE OF RS.100/- : 18 -07-2012

WITH LATE FEE OF RS.1000/- : 20 -07-2012

Examination Fee:

[A] FOR WHOLE EXAMINATION : Rs.800/-

[B] EACH THEORY / PRACTICAL SUBJECT : Rs.200/-

APPLICATIONS CAN BE HAD AT THE OFFICE OF THE PRINCIPAL AND DULY FILLED IN APPLICATIONS SHOULD BE HANDED OVER IN THE COLLEGE OFFICE WITH NECESSARY FEE.

PHARM D – SECOND YEAR REGULAR EXAMINATIONS NOTIFICATION

CANDIDATES APPEARING FOR THE ABOVE EXAMINATIONS COMMENCING FROM 30-07-2012 ARE INFORMED THAT THE APPLICATIONS WILL BE RECEIVED AS PER THE TIME SCHEDULE GIVEN BELOW:

WITHOUT LATE FEE : 16-07-2012

WITH LATE FEE OF RS.100/- : 18 -07-2012

WITH LATE FEE OF RS.1000/- : 20 -07-2012

Examination Fee:

[A] FOR WHOLE EXAMINATION : Rs.800/-

[B] EACH THEORY / PRACTICAL SUBJECT : Rs.200/-

APPLICATIONS CAN BE HAD AT THE OFFICE OF THE PRINCIPAL AND DULY FILLED IN APPLICATIONS SHOULD BE HANDED OVER IN THE COLLEGE OFFICE WITH NECESSARY FEE.

Doctor-pharma firm nexus hits drug quality

In violation of the Hippocratic Oath taken by medical practitioners, the nexus between doctors and pharmaceutical companies continues unabashedly, with doctors prescribing branded medicines based on a higher rate of commission instead of taking into account the quality of medicines. Doctors are not supposed to prescribe anything but generic names of drugs. They keep experimenting with drugs on a trial-anderror basis making guinea pigs out of patients. Dr E. Sai Prasad, former honorary secretary general of Indian Medical Association said, “In the absence of any check on the nexus between pharmaceutical companies and doctors, such practices exist widely and lot of lacunae prevail. However, doctors aren't supposed to prescribe any branded drugs to patients, but prescribe generic names only. When for a greater commission, they prescribe drugs from a lesser known company, chances are high that quality may be compromised. Again, repeatedly changing drugs if one set of medicines fails to work rapidly can be detrimental to patients, who can develop resistance to the antibiotics.“ Dr C. Hemanth, senior general physician, Yashoda Hospital added, “One of the reasons for doctors prescribing branded drugs is the non-availability of generic drugs on wider scale. Compared to thousands of drug stores in cities, there are hardly one or two generic drug stores or Jeevandhara stores.“ `Generic drugs need to be prescribed' `Changes in government policies and price ceiling on drugs is needed for the consumers' benefit. Doctors should be made to prescribe generic drugs of reputed firms with good market share, so that quality is not compromised, said Syamala Rao, founder of Jeevandhara concept in AP. SOURCE: DC

ACPE gave a clarification to Revolution PharmD regarding PCI to give ACPE Accreditation to Indian Pharm.D students

REVOLUTION PHARM.D EXCLUSIVE :

 Mike Rouse Director, International Services,Accreditation Council for Pharmacy Education (ACPE) USA issued a clarification exclusively  to Revolution Pharm.D regarding ACPE accreditation to Indian pharm.d students.He said that the  statements in  press and other media regarding PCI  to give ACPE accreditation to Indian pharm.d students are incorrect. ACPE does not provide such programmes,as was implied in the article.ACPE offers accreditation to providers of Continuing Pharmacy Education (CPE),some of which offer such educational activities.

CASE-Itchy rash on his leg

NJ is a 33-year-old man who comes to the pharmacy complaining of an itchy rash on his leg. He was working in the yard and thinks he came in contact with poison ivy. NJ says that when this has happened in the past, he has always treated it with a topical cream, but he cannot remember its name. He also mentions that his 1-year-old daughter was outside playing while he was doing yard work, and she has a little bit of a rash on her leg as well. He wants to purchase something that would be safe and effective for both of them. What would you recommend?

Answer
NJ should be counseled that when he comes in contact with poison ivy, it is important to wash the exposed area with soap and water. The quicker he washes off the exposed area, the less severe his reaction will be. For itching, you can recommend that NJ use a topical hydrocortisone cream, which can provide relief. Nonprescription oral antihistamines can also be prescribed to assist with the itching. However, it is recommended to avoid topical creams that contain antihistamines (diphenhydramine), anesthetics (benzocaine), and antibiotics (neomycin, polymycin). They generally can cause more harm than benefit. NJ’s daughter would not qualify for self-treatment because she is younger than 2 years, so she should be referred to a physician for evaluation. The Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care provides the following parameters for selftreatment in a case such as NJ and his daughter: “Exclusions for self-treatment include less than 2 years of age, dermatitis present >2 weeks, involvement of 20% of the body surface area, presence of numerous bullae, extreme itching, swelling of the body or extremities, swollen eyes or eyelids swollen shut, discomfort in genitalia from itching, signs of infection, failure to self manage after 7 days, low tolerance for pain, or impairment of daily activities.”¹

References
1. Contact dermatitis. In: Krinsky DL, Berardi RR, Ferreri SP, et al, eds. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care. 17th ed. Washington, DC: American Pharmacists Association; 2011:650.

Case-Allergic conjunctivitis

GR is a 28-year-old man who comes to the pharmacy in April complaining of itchy eyes. He explains that his eyes have been itchy for the past few weeks. He says they have been tearing more than usual as well. GR is not on any medications and has no medical conditions. Upon questioning, he says that he has been affected by seasonal allergies over the past few years. GR owns a lawn cutting company and is outside for most of his day. He has taken loratadine 10 mg in the past, but only when he had systemic symptoms. At this time, he has no other symptoms besides his itchy eyes. What would you recommend for GR?

Answer

GR is experiencing allergic conjunctivitis. The treatment goal for allergic conjunctivitis is removal or avoidance of the allergen. Because his job requires him to be outdoors, it would be difficult for GR to avoid the allergen; therefore, symptomatic relief is recommended. It is usually recommended that patients with allergic conjunctivitis be treated first-line with ocular lubricants. If symptoms continue, GR could then switch to an antihistamine/ mast cell stabilizer product. There are currently 2 such products on the market, Zaditor (Novartis) and Alaway (Bausch Lomb). Either can be recommended for use twice daily. If symptoms persist, you can suggest adding loratadine 10 mg as a second regimen.